Summit Hotel Properties Q2 Earnings Beat, Raises Full-Year Guidance on Strong RevPAR Growth
INN sits 68% above its 52-week low of $3.975.
Summary
Summit Hotel Properties reported Q2 2026 earnings that beat expectations, driven by a 5% increase in RevPAR, and raised its full-year guidance for Adjusted EBITDAre, Adjusted FFO, and RevPAR growth.
Key Events · Earnings and Guidance · INN
-
Q2 Earnings Swing to Profit
Net income attributable to common stockholders was $3.9 million ($0.04 per diluted share), compared to a net loss of $1.6 million ($0.02 loss) in Q2 2025. Total revenues rose to $199.0 million from $192.9 million.
-
RevPAR Growth Accelerates
Pro forma RevPAR increased 5.0% to $136.06, driven by a 7.1% increase in ADR to $178.42, partially offset by a 1.9% decline in occupancy to 76.3%.
-
Full-Year Guidance Raised
The company increased its 2026 outlook: Adjusted EBITDAre to $175M-$182M (midpoint +1.7%), Adjusted FFO to $95.5M-$103M (midpoint +3.4%), and Adjusted FFO per share to $0.79-$0.85 (midpoint +2.5%). Pro forma RevPAR growth is now expected at 1.75%-3.25%.
-
Balance Sheet Strengthened
During Q2, the company refinanced its $650 million senior credit facility, extending maturity to 2031 and reducing borrowing costs. It also sold two hotels for $19.0 million in July, using proceeds to pay down its revolving credit facility.
Analysis · INN · Real Estate & Construction
Summit Hotel Properties delivered a strong second quarter, swinging to a net profit of $3.9 million from a year-ago loss, with pro forma RevPAR up 5% on robust 7.1% ADR growth. Adjusted EBITDAre rose 7.7% to $54.8 million, and the company raised its full-year 2026 guidance across all key metrics, signaling management's confidence in sustained lodging demand. The balance sheet also strengthened with a refinanced $650 million credit facility and the sale of two hotels, providing additional liquidity and reducing leverage.
At the time of this filing, INN was trading at $6.67 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $827M. The 52-week trading range was $3.98 to $7.17. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.